Evidence map›Paper›PMID 41874046›Full record

ArticlePharmacy (Basel, Switzerland)2026

Impact of the COVID-19 Pandemic on Community Pharmacy Services in New Zealand: A Repeated Cross-Sectional Best-Worst Scaling Analysis.

Sepideh Sharif, Carla Dillon, Shane Scahill, Carlo Marra

Abstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sepideh SharifFaculty of Health and Sciences, Curtin University, P.O. Box U1987, Perth, WA 6845, Australia.ORCID 0000-0002-3376-8169
Carla DillonSchool of Pharmacy, Memorial University of Newfoundland, 300 Prince Philip Drive, St. John's, NL A1B 3V6, Canada.
Shane ScahillSchool of Pharmacy, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand.ORCID 0000-0001-5350-696X
Carlo MarraFaculty of Health and Sciences, Curtin University, P.O. Box U1987, Perth, WA 6845, Australia.ORCID 0000-0002-2625-2121

Funding

University of Otago NA
6 · The paper itself

Abstract

introductionThis repeated cross-sectional study examined community pharmacies in Aotearoa New Zealand and the services they provide, including retail, dispensing, and expanded scope services (e.g., minor ailment management).

methodsTwo cross-sectional surveys were conducted in 2021 (n = 504) and 2023 (n = 1000). Both assessed demographics, service use, and perceptions of pharmacists. The 2021 survey focused on trust, approachability, and role awareness, while the 2023 survey added willingness to pay, telehealth use, and comparisons with other health professionals. Best-Worst Scaling and logistic regression quantified and compared preferences.

resultsPrescription filling remained the most preferred service, while beauty product sales were least preferred. Preference for vaccination declined, indicating post-pandemic shifts in preventive care. Trust in pharmacists remained high, with strong comfort discussing health needs. Awareness of pharmacist roles improved slightly, though cost barriers persisted.

conclusionsConsumer priorities for prescription services remained stable, while interest in vaccination declined. The low preference for non-clinical retail activities suggests pharmacies should focus on health services. The high trust in pharmacists supports expanded clinical roles, but targeted policies and funding are needed to reduce cost barriers and enhance equitable access to primary healthcare.

Indexed as

Best–Worst Scalingconsumer preferenceshealthcare accessibilityhealth service usepharmacy services

Identifiers

PMID41874046
PMCPMC13010611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.